-
Study Finds Smoking Cannabis Does Not Carry Same Risks As Tobacco, No Link To Impaired Lung Functioning, COPD
Tuesday, May 23, 2023 - 1:19am | 715Cannabis smoking is not associated with an elevated risk of chronic obstructive pulmonary disease (COPD) even among those possessing a clinically high risk for developing the disease, according to a study, Impact of Marijuana Smoking on COPD Progression in a Cohort of Middle-Aged and...
-
Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers
Thursday, July 22, 2021 - 1:22pm | 373Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) started their collaboration in chronic obstructive pulmonary disorder (COPD) to target all patients, and the data is pointing them towards former smokers. What Happened: A phase 2a study, published in The...
-
'I Didn't Want To Die': Why One Woman Turned To Trading Options To Fund Life-Extending Stem Cell Treatments
Wednesday, July 31, 2019 - 3:49pm | 1585Nov. 22, 2017 started as a relatively uneventful day for Yvonne Shore. She went to her job — "the best job ever" — as a car dealership auditor in Atlanta. But for Shore, 70, the past few months had not been normal. She had been having a hard time breathing — deep breaths...
-
Theravance Just Lost Its Catalyst
Wednesday, September 9, 2015 - 1:45pm | 490Shares of Theravance Inc (NASDAQ: THRX) fell more than 12 percent Wednesday morning after the company's commercial partner, GlaxoSmithKline plc (ADR) (NYSE: GSK), disclosed topline results from SUMMIT. Theravance's trial attempted to prove survival benefits for Breo in COPD patients and failed to...